gemfibrozil has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; She, M; Zhou, Y | 1 |
| Bode, C; Klar, E; Kübler, W; Lutzi, S; Nordt, TK; Peter, K; Ruef, J; Sobel, BE | 1 |
| Bode, C; Ernst, S; Leugers, A; Nordt, TK; Sobel, BE; Willecke, F; Zirlik, A | 1 |
3 other study(ies) available for gemfibrozil and transforming growth factor beta
| Article | Year |
|---|---|
Molecular basis for the effect of lipid lowering drugs on growth factors after de-endothelialization.
Topics: Animals; Cholesterol; Endothelium, Vascular; Female; Fibroblast Growth Factor 2; Gemfibrozil; Growth Substances; Hypolipidemic Agents; Immunohistochemistry; Male; Platelet-Derived Growth Factor; Rabbits; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Simvastatin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Triglycerides; Tunica Intima | 2001 |
Attenuation by fibrates of plasminogen activator inhibitor type-1 expression in human arterial smooth muscle cells.
Topics: Aorta; Cells, Cultured; Drug Interactions; Gemfibrozil; Gene Expression Regulation; Humans; Muscle, Smooth, Vascular; Plasminogen Activator Inhibitor 1; RNA Stability; RNA, Messenger; Transforming Growth Factor beta | 2001 |
Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytes.
Topics: Adipocytes; Adipose Tissue; Adult; Aged; Animals; Cells, Cultured; Female; Fenofibrate; Gemfibrozil; Gene Expression Regulation; Humans; Hypolipidemic Agents; Mice; Mice, Inbred C57BL; Mice, Knockout; Middle Aged; Plasminogen Activator Inhibitor 1; PPAR alpha; Stem Cells; Transforming Growth Factor beta | 2009 |